Your body relies on the IFNAR1 gene to receive type I interferon signals, early immune messages that help cells slow down viruses. If this gene does not work, your immune system may struggle to control certain viral infections, and some people can become unusually ill after infections or after some live vaccines. Rare severe variants in the IFNAR1 gene can cause an inherited immune condition that may be confirmed with genetic testing.
What is a gene?
Genes are sections of DNA that give your cells instructions to make molecules or direct processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes mainly control when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
IFNAR1Gene function
What if the gene works
The IFNAR1 gene helps cells respond to type I interferons, which are immune signals released during viral infections. This supports antiviral defenses and helps guide inflammation in a controlled way.
Risk
What if the gene does not work
More disruptive variants in the IFNAR1 gene can weaken the body's interferon response, raising the chance of severe viral infections and illness after live vaccines. Milder variants may lead to later onset or a broader range of symptoms.
Treatment
What does that mean for your treatment
With a pathogenic or loss-of-function variant in the IFNAR1 gene, live attenuated viral vaccines are generally avoided because they can cause severe viral illness. Interferon alfa or beta medicines are not expected to work normally when this receptor is absent or not working. Care usually centers on prevention and early antiviral treatment rather than a drug that restores IFNAR1.
Gene function
What if the gene works
Understanding how the IFNAR1 gene helps fight viral infections begins with cell to cell messaging. If you carry this gene, it helps your cells notice type I interferons, which are immune signals released during early defense. That outside message is then passed inward, where it turns on protective programs that support a steady antiviral response.
The IFNAR1 gene helps cells receive type I interferon signals at the cell surface. It works with a partner receptor called IFNAR2 to pass that message into the cell.
After the signal arrives, IFNAR1 helps turn on genes that make the cell less welcoming to viruses. This supports the body’s early antiviral response and helps limit viral spread between cells.
IFNAR1 signaling helps immune cells and nearby tissues communicate in a more organized way. This supports a measured response that matches the body’s day to day defense needs.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help explain normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and may contribute to or directly cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IFNAR1 gene can alter the receptor’s shape, stability, or delivery to the cell surface, so cells pass along type I interferon signals less effectively. In descriptions of how IFNAR1 gene variants affect protein function, the main changes are weaker signal transfer, poorer binding, or near complete loss of receptor activity. Milder variants may leave some signaling intact, while more disruptive variants can remove it almost entirely and are linked to earlier or more severe viral illness.
How variants are linked to conditions
Pathogenic variants in the IFNAR1 gene can cause IFNAR1 deficiency, a rare inherited immune condition. People with this diagnosis are more likely to have severe illness from some viral infections and can have serious reactions to certain live weakened virus vaccines, especially measles, mumps, rubella, and yellow fever vaccines. Research also links IFNAR1 deficiency with severe COVID-19 in some people. This overview of how IFNAR1 gene variants are linked to conditions focuses on these well-established infection risks.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with disease-causing changes in the IFNAR1 gene, risk is mostly driven by the variant itself rather than by lifestyle. Exposure to certain viral infections, and in some cases live weakened-virus vaccines, can raise the chance of severe illness. Early medical follow-up and avoiding known triggers when advised can help lower the risk of complications.
Inheritance of IFNAR1 variants
Variants in the IFNAR1 gene are inherited in an autosomal recessive pattern. This means a child usually needs to inherit two disease-causing IFNAR1 gene variants, one from each parent, to have the related condition. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child without the familial variants. This is the established pattern for IFNAR1 gene inheritance.
What does my IFNAR1 result mean for my family?
For families with an IFNAR1 result linked to IFNAR1 deficiency, the condition is usually passed down in a recessive pattern. This often means parents are healthy carriers, and brothers and sisters may also be carriers or, less often, have the condition. Close relatives may want to learn whether the same gene change is present, especially when there is a family history of severe reactions to certain viral infections or live vaccines.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for IFNAR1 variants usually uses a blood sample, saliva, or a cheek swab. A lab reads the DNA in the IFNAR1 gene to look for variants that may explain a suspected inherited condition or unusual infection history. Results can show a disease causing variant, a benign variant, or an unclear finding that needs interpretation alongside symptoms and family history.
When should I consider getting a genetic test?
Consider testing if someone has had an unusually severe illness after a live virus vaccine, such as MMR or yellow fever, or repeated serious viral infections, especially in childhood. Testing can also make sense when a close family member has a harmful IFNAR1 variant or this condition.
A genetic result is only one part of your health story
Genetic results can provide meaningful information, but how much they reveal depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common, and they can influence both benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medicines. It focuses on gene-drug patterns to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. To go deeper into this subject, more details are available in the LearnHub.
Drugs influenced by the IFNAR1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices. If you have concerns about side effects, a medicine not working as expected, or treatment changes, it is best to discuss them with your doctor. IFNAR1 has been studied in relation to interferon-based treatments, but this research has not led to standard prescribing guidance.
History
Interest in the IFNAR1 gene grew out of interferon research that began in 1957, when scientists first described interferon as a natural antiviral signal. In recent decades, awareness of this gene’s role has grown as researchers mapped the two-part receptor needed for type I interferon signaling. The IFNAR1 gene was identified as one of the key receptor components during the expansion of molecular genetics in the late 20th century. Building on this early work, scientists linked changes in this gene to unusual vulnerability to certain viral infections, which helped connect laboratory findings with patient care. More recently, the IFNAR1 gene has also been part of research on interferon based treatments and immune responses during major viral outbreaks.